Morgan Stanley X Biotech Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in X Biotech Inc. stock. As of the latest transaction made, Morgan Stanley holds 105,497 shares of XBIT stock, worth $308,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,497

Previous 122,390 13.8%

Holding current value

$308,051

Previous $483,000 29.4%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.99 - $4.48 $50,510 - $75,680	-16,893 Reduced 13.8%	105,497 $341,000
Q4 2024 Feb 14, 2025	SELL	$3.8 - $8.25 $35,336 - $76,716	-9,299 Reduced 7.06%	122,390 $483,000
Q3 2024 May 14, 2025	BUY	$5.55 - $7.95 $172,815 - $247,547	31,138 Added 30.97%	131,689 $1.02 Million
Q3 2024 Nov 14, 2024	BUY	$5.55 - $7.95 $172,815 - $247,547	31,138 Added 30.97%	131,689 $1.02 Million
Q2 2024 May 14, 2025	SELL	$4.54 - $9.89 $99,149 - $215,987	-21,839 Reduced 17.84%	100,551 $516,000
Q2 2024 Oct 17, 2024	SELL	$4.54 - $9.89 $71,623 - $156,024	-15,776 Reduced 13.56%	100,551 $516,000
Q2 2024 Aug 14, 2024	SELL	$4.54 - $9.89 $71,623 - $156,024	-15,776 Reduced 13.56%	100,551 $516,000
Q1 2024 Oct 17, 2024	BUY	$4.03 - $8.13 $63,577 - $128,258	15,776 Added 15.69%	116,327 $945,000
Q1 2024 Aug 16, 2024	BUY	$4.03 - $8.13 $23,414 - $47,235	5,810 Added 5.26%	116,327 $945,000
Q1 2024 May 15, 2024	BUY	$4.03 - $8.13 $23,414 - $47,235	5,810 Added 5.26%	116,327 $945,000
Q4 2023 Aug 16, 2024	BUY	$3.56 - $4.65 $35,478 - $46,341	9,966 Added 9.91%	110,517 $442,000
Q4 2023 Feb 13, 2024	BUY	$3.56 - $4.65 $82,912 - $108,298	23,290 Added 26.7%	110,517 $442,000
Q3 2023 Nov 15, 2023	BUY	$4.02 - $5.81 $13,390 - $19,353	3,331 Added 3.97%	87,227 $359,000
Q2 2023 Aug 14, 2023	SELL	$3.06 - $6.38 $10,437 - $21,762	-3,411 Reduced 3.91%	83,896 $498,000
Q1 2023 May 15, 2023	SELL	$3.22 - $4.72 $35,581 - $52,156	-11,050 Reduced 11.23%	87,307 $301,000
Q4 2022 Feb 14, 2023	SELL	$3.03 - $3.79 $44,847 - $56,095	-14,801 Reduced 13.08%	98,357 $345,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $317,331 - $521,203	-88,640 Reduced 43.93%	113,158 $409,000
Q2 2022 Oct 27, 2022	BUY	$5.13 - $9.2 $848,409 - $1.52 Million	165,382 Added 454.15%	201,798 $1.13 Million
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $848,409 - $1.52 Million	165,382 Added 454.15%	201,798 $1.13 Million
Q1 2022 Oct 27, 2022	SELL	$8.64 - $11.71 $1.43 Million - $1.94 Million	-165,382 Reduced 81.95%	36,416 $315,000
Q1 2022 May 13, 2022	BUY	$8.64 - $11.71 $133,297 - $180,661	15,428 Added 73.51%	36,416 $315,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $94,629 - $138,876	8,642 Added 70.0%	20,988 $234,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $159,880 - $225,191	12,346 New	12,346 $159,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.3M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $88.9M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account